BRACE

BRACE Therapeutics is a clinical-stage biopharmaceutical company and strategic investment firm focused on developing innovative therapies for patients with high unmet medical needs, particularly in the areas of orphan diseases, oncology, and central nervous system disorders. Founded as a partnership between EMS, Brazil's largest pharmaceutical company, and other strategic investors, BRACE operates a unique model that combines direct drug development with venture capital investment. The company's portfolio includes a diverse range of modalities, including small molecules and biologics, targeting complex pathways such as the complement system and lysosomal enzymes. BRACE aims to accelerate the clinical progression of promising science through its global network and financial resources.